Inventor
ACKERMANN DOUGLAS MICHAEL
US55 patents
⚠️ This page may combine multiple inventors who share the name “ACKERMANN DOUGLAS MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OCULEVE INC
20 patentsUS10238861B2Mar 26, 2019
Nasal stimulation devices and methods for treating dry eye
OCULEVE INC28 citations98
US10155108B2Dec 18, 2018
Nasal stimulation devices and methods
OCULEVE INC36 citations98
US9265956B2Feb 23, 2016
Devices and methods for treating dry eye in animals
OCULEVE INC62 citations98
US8996137B2Mar 31, 2015
Nasal stimulation devices and methods
OCULEVE INC109 citations98
US9737702B2Aug 22, 2017
Nasal stimulation devices and methods
OCULEVE INC56 citations97
US9440065B2Sep 13, 2016
Nasal stimulation devices and methods
OCULEVE INC66 citations97
US10252048B2Apr 9, 2019
Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
OCULEVE INC38 citations94
US9764150B2Sep 19, 2017
Contact lens for increasing tear production
OCULEVE INC37 citations94
USD837396SJan 1, 2019
Nasal stimulator probe
OCULEVE INC14 citations93
USD826420SAug 21, 2018
Nasal stimulator device
OCULEVE INC29 citations93
US9717627B2Aug 1, 2017
Implant delivery devices, systems, and methods
OCULEVE INC33 citations93
US10940310B2Mar 9, 2021
Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
OCULEVE INC9 citations85
USD907791SJan 12, 2021
Nasal stimulator body
OCULEVE INC8 citations83
US10835748B2Nov 17, 2020
Stimulation devices and methods
OCULEVE INC6 citations83
US10207108B2Feb 19, 2019
Implantable nasal stimulator systems and methods
OCULEVE INC17 citations83
US10967173B2Apr 6, 2021
Nasal stimulation devices and methods for treating dry eye
OCULEVE INC1 citations73
US10799695B2Oct 13, 2020
Nasal stimulation devices and methods
OCULEVE INC1 citations73
US10610695B2Apr 7, 2020
Implantable device for increasing tear production
OCULEVE INC2 citations73
US10426958B2Oct 1, 2019
Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
OCULEVE INC4 citations73
US10328262B2Jun 25, 2019
Stimulation devices and methods
OCULEVE INC2 citations72
PRESIDIO MEDICAL INC
9 patentsUS10272240B2Apr 30, 2019
Systems and methods for direct current nerve conduction block
PRESIDIO MEDICAL INC15 citations94
US11027126B2Jun 8, 2021
Systems and methods for direct current nerve conduction block
PRESIDIO MEDICAL INC13 citations85
US12268865B2Apr 8, 2025
Current bias as a control mechanism for electrode operation
PRESIDIO MEDICAL INC3 citations73
US11918803B2Mar 5, 2024
Systems and methods for direct current nerve conduction block
PRESIDIO MEDICAL INC2 citations73
US11730964B2Aug 22, 2023
Pulse generation and stimulation engine systems
PRESIDIO MEDICAL INC4 citations72
US11813459B2Nov 14, 2023
Methods and systems for nerve conduction block
PRESIDIO MEDICAL INC2 citations71
US11752329B2Sep 12, 2023
Systems and methods for nerve conduction block
PRESIDIO MEDICAL INC2 citations71
US12558551B2Feb 24, 2026
Pulse generation and stimulation engine systems
PRESIDIO MEDICAL INC0 citations60
US12465260B2Nov 11, 2025
Systems and methods for cardiac conduction block
PRESIDIO MEDICAL INC0 citations60
TARSUS PHARMACEUTICALS INC
8 patentsUS11197847B2Dec 14, 2021
Isoxazoline parasiticide formulations and methods for treating blepharitis
TARSUS PHARMACEUTICALS INC11 citations93
US10835517B2Nov 17, 2020
Methods for treating ocular demodex using isoxazoline parasiticide formulations
TARSUS PHARMACEUTICALS INC12 citations93
US11752137B2Sep 12, 2023
Ophthalmic compositions for treating ocular Demodex using lotilaner formulations
TARSUS PHARMACEUTICALS INC4 citations85
US11690826B2Jul 4, 2023
Methods for treating demodex blepharitis using lotilaner formulations
TARSUS PHARMACEUTICALS INC6 citations85
US11690827B2Jul 4, 2023
Methods for treating ocular Demodex using lotilaner formulations
TARSUS PHARMACEUTICALS INC6 citations85
US12364685B2Jul 22, 2025
Isoxazoline parasiticide formulations
TARSUS PHARMACEUTICALS INC1 citations74
US12213964B2Feb 4, 2025
Isoxazoline parasiticide formulations
TARSUS PHARMACEUTICALS INC2 citations74
US12171750B2Dec 24, 2024
Isoxazoline parasiticide formulations and methods for treating blepharitis
TARSUS PHARMACEUTICALS INC2 citations72
UNIV LELAND STANFORD JUNIOR
4 patentsUS9095723B2Aug 4, 2015
Systems and methods for treatment of dry eye
UNIV LELAND STANFORD JUNIOR38 citations97
US10143846B2Dec 4, 2018
Systems and methods for treatment of dry eye
UNIV LELAND STANFORD JUNIOR19 citations93
US10722718B2Jul 28, 2020
Systems and methods for treatment of dry eye
UNIV LELAND STANFORD JUNIOR1 citations72
US11771908B2Oct 3, 2023
Systems and methods for treatment of dry eye
UNIV LELAND STANFORD JUNIOR0 citations62
ACKERMANN DOUGLAS MICHAEL
2 patentsTANGIBLE SCIENCE INC
2 patentsTAHMASIAN SAMUEL
1 patentBOSTON SCIENT NEUROMODULATION
1 patentOCULAR DYNAMICS LLC
1 patentOYSTER POINT PHARMA INC
1 patentPIANCA ANNE MARGARET
1 patentShowing the top 50 of 55 patents by PatentIndex Score.